Skip to main content
Equibles

Fred B. Craves, Ph.D.

Board Member

Madrigal Pharmaceuticals, Inc. (MDGL)

Equibles does not estimate personal net worth.

Get an email with a short summary when Madrigal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get MDGL alerts

About Fred B. Craves, Ph.D.

Fred B. Craves, Ph.D. is recorded as Board Member at Madrigal Pharmaceuticals, Inc. (MDGL) since June 25, 2024. Madrigal Pharmaceuticals, Inc. reported in an 8-K filed March 11, 2025 that Fred B. Craves, Ph.D. resigned as Board of Directors, effective July 1, 2025. Madrigal Pharmaceuticals, Inc. reported in an 8-K filed June 27, 2024 that Fred B. Craves, Ph.D. was appointed Class II Nominee, effective June 25, 2024. Madrigal Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Madrigal Pharmaceuticals, Inc. includes Bill Sibold (CEO and Board Member), Julian C. Baker (Chairman and Board Member), Mardi Dier (CFO) and 7 others.

“On March 9, 2025, Fred Craves, Ph.D. provided notice of his resignation from the Board of Directors (the "Board") of Madrigal Pharmaceuticals, Inc. (the "Company"), effective as of July 1, 2025.”
Madrigal Pharmaceuticals, Inc. Form 8-K, filed March 11, 2025 · Read the filing
“The Company's stockholders elected each of the three Class II nominees named below to serve on the Company's Board of Directors for a three-year term expiring at the Company's 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified.”
Madrigal Pharmaceuticals, Inc. Form 8-K, filed June 27, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Madrigal Pharmaceuticals, Inc.

Recent activity